DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/nm7zcc/molecular) has announced the addition of the "Molecular Diagnostics Partnering Terms and Agreements" report to their offering.
The Molecular Diagnostics Partnering Terms and Agreements report provides a detailed understanding and analysis of how and why companies enter molecular diagnostics partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases and databases do not.
This report contains a comprehensive listing of all molecular diagnostics partnering deals announced since 2009 including financial terms where available including over 300 links to online deal records of actual molecular diagnostics partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners.
Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.
Molecular Diagnostics Partnering Agreements includes:
- Trends in molecular diagnostics dealmaking in the biopharma industry since 2009
- Analysis of molecular diagnostics deal structure
- Access to headline, upfront, milestone and royalty data
- Access to over 300 molecular diagnostics deal records
- The leading molecular diagnostics deals by value since 2009
In Molecular Diagnostics Partnering Agreements, the available deals are listed by:
- Company A-Z
- Headline value
- Stage of development at signing
- Deal component type
- Specific diagnostics technology type
- Aspen Pharmacare
- Boehringer Ingelheim
- Watson Pharmaceuticals
For more information visit http://www.researchandmarkets.com/research/nm7zcc/molecular
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.